Simpson Thacher Represents Underwriters in the NASDAQ IPO of Burning Rock
06.17.20
This is only gets display when printing
Simpson Thacher represented the underwriters in connection with the initial public offering and listing on the NASDAQ Global Market of Burning Rock Biotech Limited (“Burning Rock”). The offering was comprised of 13,500,000 American Depositary Shares (“ADSs”), representing 13,500,000 Class A ordinary shares before exercise of the underwriters’ overallotment option. The base offering size was approximately US$222.8 million. Morgan Stanley, BofA Securities and Cowen acted as the representatives of the underwriters.
Burning Rock is a leading cancer therapy selection company in China, aiming to transform precision oncology and early cancer detection. Its cancer therapy selection platform is built upon advanced technologies, comprehensive portfolio of products and a market-driven commercial infrastructure. Burning Rock’s ADSs are traded on the NASDAQ Global Market under the symbol “BNR.”
The Simpson Thacher team for the transaction included Chris Lin, Daniel Fertig and Chenjing Shen (Capital Markets); Jonathan Cantor and Sergio Torres (Tax); and Jennie Getsin (FINRA and Blue Sky). Vanessa Burrows also provided valuable advice on biotech-related matters.